Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
T4P1001 for Peripheral Neuropathic Pain
NCT02301169Completed
- Sponsor
- Cognivia
- Start
- Mar 2014
- Primary completion
- Nov 2014
- Modality
- Placebo
- Countries
- 1
01
Overview
Randomised, double-blind trial of T4P1001 in Peripheral neuropathic pain, sponsored by Cognivia. Primary endpoint: Average Pain Score at 4 weeks. Started Mar 2014; status: completed.
02
Drugs
T4P1001
03
Conditions
Peripheral neuropathic pain
Beyond the preview
Go deeper on NCT02301169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02301169.